Literature DB >> 20147599

Contrasting two frameworks for ROC analysis of ordinal ratings.

Daryl E Morris1, Margaret Sullivan Pepe, William E Barlow.   

Abstract

BACKGROUND: Statistical evaluation of medical imaging tests used for diagnostic and prognostic purposes often employs receiver operating characteristic (ROC) curves. Two methods for ROC analysis are popular. The ordinal regression method is the standard approach used when evaluating tests with ordinal values. The direct ROC modeling method is a more recently developed approach, motivated by applications to tests with continuous values.
OBJECTIVE: The authors compare the methods in terms of model formulations, interpretations of estimated parameters, the ranges of scientific questions that can be addressed with them, their computational algorithms, and the efficiencies with which they use data.
RESULTS: The authors show that a strong relationship exists between the methods by demonstrating that they fit the same models when only a single test is evaluated. The ordinal regression models are typically alternative parameterizations of the direct ROC models and vice versa. The direct method has two major advantages over the ordinal regression method: 1) estimated parameters relate directly to ROC curves, facilitating interpretations of covariate effects on ROC performance, and 2) comparisons between tests can be done directly in this framework. Comparisons can be made while accommodating covariate effects and even between tests that have values on different scales, such as between a continuous biomarker test and an ordinal valued imaging test. The ordinal regression method provides slightly more precise parameter estimates from data in our simulated data models.
CONCLUSION: Although the ordinal regression method is slightly more efficient, the direct ROC modeling method has important advantages in regard to interpretation, and it offers a framework to address a broader range of scientific questions, including the facility to compare tests.

Entities:  

Mesh:

Year:  2010        PMID: 20147599      PMCID: PMC2905510          DOI: 10.1177/0272989X09357477

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  12 in total

1.  The analysis of placement values for evaluating discriminatory measures.

Authors:  Margaret Sullivan Pepe; Tianxi Cai
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

2.  Accuracy of screening mammography interpretation by characteristics of radiologists.

Authors:  William E Barlow; Chen Chi; Patricia A Carney; Stephen H Taplin; Carl D'Orsi; Gary Cutter; R Edward Hendrick; Joann G Elmore
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

3.  Assessing accuracy of mammography in the presence of verification bias and intrareader correlation.

Authors:  Yingye Zheng; William E Barlow; Gary Cutter
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting.

Authors:  Holly Janes; Margaret S Pepe
Journal:  Am J Epidemiol       Date:  2008-05-13       Impact factor: 4.897

5.  Three approaches to regression analysis of receiver operating characteristic curves for continuous test results.

Authors:  M S Pepe
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

6.  Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve.

Authors:  Holly Janes; Margaret S Pepe
Journal:  Biometrika       Date:  2009-04-01       Impact factor: 2.445

7.  A general regression methodology for ROC curve estimation.

Authors:  A N Tosteson; C B Begg
Journal:  Med Decis Making       Date:  1988 Jul-Sep       Impact factor: 2.583

8.  Estimation and Comparison of Receiver Operating Characteristic Curves.

Authors:  Margaret Pepe; Gary Longton; Holly Janes
Journal:  Stata J       Date:  2009-03-01       Impact factor: 2.637

9.  Accommodating Covariates in ROC Analysis.

Authors:  Holly Janes; Gary Longton; Margaret Pepe
Journal:  Stata J       Date:  2009-01-01       Impact factor: 2.637

10.  Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Authors:  Margaret S Pepe; Ziding Feng; Holly Janes; Patrick M Bossuyt; John D Potter
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

View more
  6 in total

1.  Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates.

Authors:  Margaret Sullivan Pepe; Jing Fan; Christopher W Seymour
Journal:  Acad Radiol       Date:  2013-04-17       Impact factor: 3.173

2.  Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study.

Authors:  Yook Chin Chia; Sarah Yu Weng Gray; Siew Mooi Ching; Hooi Min Lim; Karuthan Chinna
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

3.  More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.

Authors:  James Michael Menke; Md Shahidul Ahsan; Suan Phaik Khoo
Journal:  Biomark Cancer       Date:  2017-10-17

Review 4.  Unified Least Squares Methods for the Evaluation of Diagnostic Tests With the Gold Standard.

Authors:  Liansheng Larry Tang; Ao Yuan; John Collins; Xuan Che; Leighton Chan
Journal:  Cancer Inform       Date:  2017-02-03

5.  Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot.

Authors:  Mohsen Sadatsafavi; Paramita Saha-Chaudhuri; John Petkau
Journal:  Med Decis Making       Date:  2021-10-16       Impact factor: 2.583

6.  Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction.

Authors:  Benjamin Lidgard; Leila R Zelnick; Alan Go; Kevin D O'Brien; Nisha Bansal
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.